-- 据周四深圳证券交易所披露的信息，河北常山生化药业（深交所代码：300255）已获得白俄罗斯药品监管机构颁发的达肝素钠注射液药品注册证书。 该药用于治疗急性深静脉血栓形成和不稳定型冠状动脉疾病。
Related Articles
Japan
US 10-Yr Treasury Yield Slips 1.8 Basis Points to 4.34%, Extending Drop From Highest in About a Month
Asia
Mencast Grants Nearly 3 Million Shares Under Performance Award Scheme
Mencast (SGX:5NF) granted 2.9 million shares under the company's performance share award scheme, according to a Thursday filing with the Singapore Exchange.The awards will vest immediately upon granting, the filing stated.
$SGX:5NF
Mining & Metals
Earnings Flash (MFI.TO) Maple Leaf Foods Reports Q1 Revenue $962.9M
$MFI.TO